デフォルト表紙
市場調査レポート
商品コード
1717033

血行動態改善装置の世界市場レポート 2025年

Hemodynamic Flow Alteration Devices Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
血行動態改善装置の世界市場レポート 2025年
出版日: 2025年04月29日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血行動態改善装置市場規模は、今後数年間で力強い成長が見込まれます。2029年には12億1,000万米ドルに成長し、CAGRは7.9%となります。予測期間中の成長は、神経血管疾患の有病率の増加、低侵襲脳外科手術の需要拡大、老人患者の増加、血栓イベントのリスク増加、可処分所得の増加などの要因に起因すると考えられます。予測期間における主な動向としては、低侵襲手術の採用、生体適合材料の発展、ウェアラブル・モニタリング・システムの開発、人工知能と機械学習の統合、これらの機器と心臓モニタリング・システムの組み込みなどが挙げられます。

心血管疾患の有病率の増加は、血行動態改善装置市場の拡大を促進すると予想されます。心血管疾患(CVD)には、心臓や血管に影響を及ぼすさまざまな疾患が含まれます。CVD患者の増加は、主に高齢化、不健康な食生活、座りがちなライフスタイル、高血圧や糖尿病などの疾患の増加率などの要因に起因しています。血行動態改善装置は、心不全、高血圧、動脈閉塞などの心血管系疾患の患者の血流を管理するために極めて重要です。例えば、英国を拠点とする心臓血管研究の慈善団体である英国心臓財団(British Heart Foundation)の報告によると、英国では約760万人が心臓・循環器疾患を抱えており、そのうち男性400万人、女性360万人が罹患しています。2030年までにこの数は100万人増加し、2040年までにさらに200万人増加すると予測されています。このように、心血管疾患の有病率の増加は、血行動態改善装置市場の重要な促進要因となっています。

血行動態改善装置市場の主要企業は、より良い心臓補助を提供し、患者の予後を改善し、世界中で増加する心不全の発生率に対処するため、左室補助循環装置(LVAD)などの先進ソリューションの開発に注力しています。LVADは、重度の心不全患者に植え込まれ、血液を送り出す心臓を補助する機械式ポンプです。例えば、2022年1月、インドの政府系研究機関であるインド工科大学カーンプル校は、Hridyantraと呼ばれるイニシアチブを開始しました。このプロジェクトは、末期心不全患者のニーズに応える最先端のLVADの開発を目指しています。この装置は、心臓移植への橋渡しとしての役割を果たすか、移植の候補に挙がっていない患者のための長期的な解決策を提供することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界血行動態改善装置 PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の血行動態改善装置市場:成長率分析
  • 世界の血行動態改善装置市場の実績:規模と成長, 2019-2024
  • 世界の血行動態改善装置市場の予測:規模と成長, 2024-2029, 2034F
  • 世界血行動態改善装置総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の血行動態改善装置市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 塞栓保護デバイス
  • 慢性完全閉塞デバイス
  • 世界の血行動態改善装置市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 心血管疾患
  • 神経疾患
  • 腎疾患
  • 呼吸器疾患
  • 世界の血行動態改善装置市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • クリニック
  • 外来診療センター
  • 在宅ケア環境
  • その他のエンドユーザー
  • 世界の血行動態改善装置市場塞栓保護デバイスのサブセグメンテーション(タイプ別)、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 遠位塞栓保護デバイス
  • 近位塞栓保護デバイス
  • フィルターベースの塞栓保護デバイス
  • バルーンベースの塞栓保護デバイス
  • メッシュまたはケージベースの塞栓保護デバイス
  • 世界の血行動態改善装置市場慢性完全閉塞デバイスのサブセグメンテーション(タイプ別)、実績と予測, 2019-2024, 2024-2029F, 2034F
  • CTO用クロッシングガイドワイヤー
  • CTOバルーンカテーテル
  • CTOマイクロカテーテル
  • CTO用再突入装置
  • CTOサポートカテーテル

第7章 地域別・国別分析

  • 世界の血行動態改善装置市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の血行動態改善装置市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 血行動態改善装置市場:競合情勢
  • 血行動態改善装置市場:企業プロファイル
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Stryker Corporation
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • W. L. Gore & Associates Inc.
  • ZOLL Medical Corporation
  • Getinge AB
  • Lepu Medical Technology(Beijing)Co. Ltd.
  • Abiomed Inc.
  • LivaNova PLC
  • Cordis US Corp.
  • Silk Road Medical Inc.
  • Berlin Heart GmbH
  • CorWave SA
  • Jarvik Heart Inc.
  • CARMAT SA

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 血行動態改善装置市場2029:新たな機会を提供する国
  • 血行動態改善装置市場2029:新たな機会を提供するセグメント
  • 血行動態改善装置市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r33761

Hemodynamic flow alteration devices are medical instruments designed to modify the dynamics of blood flow within the circulatory system. These devices are often utilized in procedures such as vascular surgery or heart condition treatments. They can influence factors such as the speed, direction, or resistance of blood flow to enhance circulation or reduce strain on vital organs.

The primary types of hemodynamic flow alteration devices include embolic protection devices and chronic total occlusion devices. An embolic protection device is specifically designed to capture and remove embolic material that may become dislodged during procedures such as angioplasty. This prevents the material from traveling to vital organs and causing blockages. These devices are used in various applications, including cardiovascular diseases, neurological disorders, renal conditions, and respiratory disorders, and are employed by several end users, including hospitals, clinics, ambulatory care centers, home care settings, and more.

The hemodynamic flow alteration devices market research report is one of a series of new reports from The Business Research Company that provides hemodynamic flow alteration devices market statistics, including the hemodynamic flow alteration devices industry global market size, regional shares, competitors with the hemodynamic flow alteration devices market share, detailed hemodynamic flow alteration devices market segments, market trends, and opportunities, and any further data you may need to thrive in the hemodynamic flow alteration devices industry. This hemodynamic flow alteration devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hemodynamic flow alteration devices market size has grown strongly in recent years. It will grow from $0.82 billion in 2024 to $0.89 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth during the historic period can be attributed to factors such as the expanding aging population, increased healthcare expenditure, a rise in the prevalence of cardiovascular diseases, growing risk factors such as obesity, diabetes, and hypertension, and increased investment in research and development.

The hemodynamic flow alteration devices market size is expected to see strong growth in the next few years. It will grow to $1.21 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth during the forecast period can be attributed to factors such as the increasing prevalence of neurovascular diseases, a growing demand for minimally invasive neurosurgery, a rise in geriatric patients, an increased risk of thrombotic events, and rising disposable incomes. Key trends in the forecast period include the adoption of minimally invasive procedures, advancements in biocompatible materials, the development of wearable monitoring systems, the integration of artificial intelligence and machine learning, and the incorporation of these devices with cardiac monitoring systems.

The growing prevalence of cardiovascular diseases is expected to drive the expansion of the hemodynamic flow alteration devices market. Cardiovascular disease (CVD) encompasses a range of conditions affecting the heart and blood vessels. The rise in CVD cases is primarily attributed to factors such as aging populations, unhealthy diets, sedentary lifestyles, and increasing rates of conditions such as hypertension and diabetes. Hemodynamic flow alteration devices are crucial for managing blood flow in patients with cardiovascular conditions such as heart failure, hypertension, and arterial blockages. For example, a report by the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are living with heart and circulatory diseases, with 4 million men and 3.6 million women affected. By 2030, this number is projected to increase by 1 million, and by 2040, it could rise by an additional 2 million. Thus, the growing prevalence of cardiovascular diseases is a key driver for the hemodynamic flow alteration devices market.

Leading companies in the hemodynamic flow alteration devices market are focusing on the development of advanced solutions such as left ventricular assist devices (LVADs) to provide better cardiac support, improve patient outcomes, and tackle the rising incidence of heart failure worldwide. An LVAD is a mechanical pump implanted in patients with severe heart failure to assist the heart in pumping blood. For example, in January 2022, the Indian Institute of Technology-Kanpur, a government research institute based in India, launched an initiative called Hridyantra. This project aims to develop a cutting-edge LVAD to meet the needs of patients with end-stage heart failure. The device is intended to either serve as a bridge to a heart transplant or provide a long-term solution for those who are not candidates for a transplant.

In October 2024, Johnson & Johnson, a pharmaceutical company based in the US, acquired V-Wave Inc. for an undisclosed sum. This acquisition is intended to bolster Johnson & Johnson's position in the cardiovascular disease sector by adding V-Wave's groundbreaking Ventura interatrial shunt to its MedTech portfolio. V-Wave Inc., a US-based company, specializes in the development of hemodynamic flow alteration devices.

Major players in the hemodynamic flow alteration devices market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., ZOLL Medical Corporation, Getinge AB, Lepu Medical Technology (Beijing) Co. Ltd., Abiomed Inc., LivaNova PLC, Cordis US Corp., Silk Road Medical Inc., Berlin Heart GmbH, CorWave SA, Jarvik Heart Inc., and CARMAT SA.

North America was the largest region in the hemodynamic flow alteration devices market in 2024. The regions covered in hemodynamic flow alteration devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hemodynamic flow alteration devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemodynamic flow alteration devices market consists of sales of flow diverters, vascular stents, blood flow regulators, and monitoring tools. Values in and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemodynamic Flow Alteration Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemodynamic flow alteration devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemodynamic flow alteration devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemodynamic flow alteration devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Embolic Protection Device; Chronic Total Occlusion Device
  • 2) By Application: Cardiovascular Diseases; Neurological Disorders; Renal Disorders; Respiratory Disorders
  • 3) By End User: Hospitals; Clinics; Ambulatory Care Centre; Home Care Setting; Other End Users
  • Subsegments:
  • 1) By Embolic Protection Device: Distal Embolic Protection Devices; Proximal Embolic Protection Devices; Filter-Based Embolic Protection Devices; Balloon-Based Embolic Protection Devices; Mesh Or Cage-Based Embolic Protection Devices
  • 2) By Chronic Total Occlusion Device: Crossing Guidewires For CTO; CTO Balloon Catheters; CTO Microcatheters; Re-Entry Devices For CTO; CTO Support Catheters
  • Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic plc; Siemens Healthcare GmbH; Becton Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemodynamic Flow Alteration Devices Market Characteristics

3. Hemodynamic Flow Alteration Devices Market Trends And Strategies

4. Hemodynamic Flow Alteration Devices Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hemodynamic Flow Alteration Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hemodynamic Flow Alteration Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hemodynamic Flow Alteration Devices Market Growth Rate Analysis
  • 5.4. Global Hemodynamic Flow Alteration Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hemodynamic Flow Alteration Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hemodynamic Flow Alteration Devices Total Addressable Market (TAM)

6. Hemodynamic Flow Alteration Devices Market Segmentation

  • 6.1. Global Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Embolic Protection Device
  • Chronic Total Occlusion Device
  • 6.2. Global Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Diseases
  • Neurological Disorders
  • Renal Disorders
  • Respiratory Disorders
  • 6.3. Global Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Care Centre
  • Home Care Setting
  • Other End Users
  • 6.4. Global Hemodynamic Flow Alteration Devices Market, Sub-Segmentation Of Embolic Protection Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Distal Embolic Protection Devices
  • Proximal Embolic Protection Devices
  • Filter-Based Embolic Protection Devices
  • Balloon-Based Embolic Protection Devices
  • Mesh Or Cage-Based Embolic Protection Devices
  • 6.5. Global Hemodynamic Flow Alteration Devices Market, Sub-Segmentation Of Chronic Total Occlusion Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Crossing Guidewires For CTO
  • CTO Balloon Catheters
  • CTO Microcatheters
  • Re-Entry Devices For CTO
  • CTO Support Catheters

7. Hemodynamic Flow Alteration Devices Market Regional And Country Analysis

  • 7.1. Global Hemodynamic Flow Alteration Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hemodynamic Flow Alteration Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemodynamic Flow Alteration Devices Market

  • 8.1. Asia-Pacific Hemodynamic Flow Alteration Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemodynamic Flow Alteration Devices Market

  • 9.1. China Hemodynamic Flow Alteration Devices Market Overview
  • 9.2. China Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemodynamic Flow Alteration Devices Market

  • 10.1. India Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemodynamic Flow Alteration Devices Market

  • 11.1. Japan Hemodynamic Flow Alteration Devices Market Overview
  • 11.2. Japan Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemodynamic Flow Alteration Devices Market

  • 12.1. Australia Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemodynamic Flow Alteration Devices Market

  • 13.1. Indonesia Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemodynamic Flow Alteration Devices Market

  • 14.1. South Korea Hemodynamic Flow Alteration Devices Market Overview
  • 14.2. South Korea Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemodynamic Flow Alteration Devices Market

  • 15.1. Western Europe Hemodynamic Flow Alteration Devices Market Overview
  • 15.2. Western Europe Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemodynamic Flow Alteration Devices Market

  • 16.1. UK Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemodynamic Flow Alteration Devices Market

  • 17.1. Germany Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemodynamic Flow Alteration Devices Market

  • 18.1. France Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemodynamic Flow Alteration Devices Market

  • 19.1. Italy Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemodynamic Flow Alteration Devices Market

  • 20.1. Spain Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemodynamic Flow Alteration Devices Market

  • 21.1. Eastern Europe Hemodynamic Flow Alteration Devices Market Overview
  • 21.2. Eastern Europe Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemodynamic Flow Alteration Devices Market

  • 22.1. Russia Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemodynamic Flow Alteration Devices Market

  • 23.1. North America Hemodynamic Flow Alteration Devices Market Overview
  • 23.2. North America Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemodynamic Flow Alteration Devices Market

  • 24.1. USA Hemodynamic Flow Alteration Devices Market Overview
  • 24.2. USA Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemodynamic Flow Alteration Devices Market

  • 25.1. Canada Hemodynamic Flow Alteration Devices Market Overview
  • 25.2. Canada Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemodynamic Flow Alteration Devices Market

  • 26.1. South America Hemodynamic Flow Alteration Devices Market Overview
  • 26.2. South America Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemodynamic Flow Alteration Devices Market

  • 27.1. Brazil Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemodynamic Flow Alteration Devices Market

  • 28.1. Middle East Hemodynamic Flow Alteration Devices Market Overview
  • 28.2. Middle East Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemodynamic Flow Alteration Devices Market

  • 29.1. Africa Hemodynamic Flow Alteration Devices Market Overview
  • 29.2. Africa Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemodynamic Flow Alteration Devices Market Competitive Landscape And Company Profiles

  • 30.1. Hemodynamic Flow Alteration Devices Market Competitive Landscape
  • 30.2. Hemodynamic Flow Alteration Devices Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Hemodynamic Flow Alteration Devices Market Other Major And Innovative Companies

  • 31.1. Stryker Corporation
  • 31.2. Boston Scientific Corporation
  • 31.3. Edwards Lifesciences Corporation
  • 31.4. W. L. Gore & Associates Inc.
  • 31.5. ZOLL Medical Corporation
  • 31.6. Getinge AB
  • 31.7. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.8. Abiomed Inc.
  • 31.9. LivaNova PLC
  • 31.10. Cordis US Corp.
  • 31.11. Silk Road Medical Inc.
  • 31.12. Berlin Heart GmbH
  • 31.13. CorWave SA
  • 31.14. Jarvik Heart Inc.
  • 31.15. CARMAT SA

32. Global Hemodynamic Flow Alteration Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemodynamic Flow Alteration Devices Market

34. Recent Developments In The Hemodynamic Flow Alteration Devices Market

35. Hemodynamic Flow Alteration Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Hemodynamic Flow Alteration Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hemodynamic Flow Alteration Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hemodynamic Flow Alteration Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer